NLS COVID-19

Pfizer is seeking Emergency Use Authorization (EUA) of its investigational oral antiviral candidate, PAXLOVID, for the treatment of mild to moderate COVID-19 in patients at increased risk of hospitalizations or death. This submission to the U.S. Food and Drug Administration (FDA) includes clinical data from the Phase 2/3 EPIC-HR (Evaluation of Protease Inhibition for COVID-19 […]

Zipline, Pfizer and BioNTech has announced that Zipline has successfully completed the first long-range drone delivery of both authorized mRNA COVID-19 vaccines requiring ultra-cold-chain in Ghana. The collaboration of the companies, which worked together earlier this year to develop and test an end-to-end vaccine delivery solution, will allow for the distribution of approximately 50,000 doses […]

Researchers at the University of Helsinki and the University of Eastern Finland first searched for suitable drug targets and repurposable drugs for treatment options for COVID-19. They found six candidate drugs that demonstrate antiviral effects against SARS-CoV-2. “To effectively search for drugs that could modify viral replication, we need to know which human proteins and […]

Merck and Ridgeback’s Molnupiravir, an oral COVID-19 antiviral medicine, receives first authorization in the world. U.K.’s Medicines and Healthcare Products Regulatory Agency authorizes Molnupiravir for the treatment of mild-to-moderate COVID-19 in adults with a positive SARS-CoV-2 diagnostic test and who have at least one risk factor for developing severe illness. In the U.K., LAGEVRIO (lah-GEV-ree-oh) is […]

Antibodies in the airways quickly wane after SARS-CoV-2 infection, but vaccination results in a strong increase in antibody levels, especially after two doses, according to a new study from Karolinska Institutet in Sweden published in the journal JCI Insight. The results suggest that having a second dose of vaccine also after recovering from COVID-19 may […]

Scientist and company founder Per Gisle Djupesland’s invention could be used to treat symptoms and transmission of COVID-19. Targeted drug delivery is critical when treating chronic inflammatory nasal and sinus diseases. Medicine could be deposited in the wrong areas, swallowed or passed straight through the nasal passages into the lungs, and traditional spray pumps cannot […]